1. Home
  2. LRCX vs NVS Comparison

LRCX vs NVS Comparison

Compare LRCX & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lam Research Corporation

LRCX

Lam Research Corporation

HOLD

Current Price

$225.19

Market Cap

273.7B

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$154.88

Market Cap

310.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRCX
NVS
Founded
1980
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7B
310.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
LRCX
NVS
Price
$225.19
$154.88
Analyst Decision
Strong Buy
Hold
Analyst Count
25
4
Target Price
$241.79
$118.00
AVG Volume (30 Days)
7.6M
2.2M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
0.46%
2.00%
EPS Growth
N/A
N/A
EPS
2.50
N/A
Revenue
$3,237,693,000.00
N/A
Revenue This Year
$23.89
$2.56
Revenue Next Year
$24.37
$4.91
P/E Ratio
$89.56
$23.13
Revenue Growth
51.74
N/A
52 Week Low
$57.97
$97.72
52 Week High
$256.68
$170.46

Technical Indicators

Market Signals
Indicator
LRCX
NVS
Relative Strength Index (RSI) 52.15 42.57
Support Level $213.87 $122.16
Resistance Level $254.28 $158.80
Average True Range (ATR) 8.67 2.47
MACD -1.07 -1.86
Stochastic Oscillator 55.10 8.97

Price Performance

Historical Comparison
LRCX
NVS

About LRCX Lam Research Corporation

Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: